Results 181 to 190 of about 105,256 (302)

Prevalence and Blood Biochemical Parameters Associated with Sarcopenia Among Korean Postmenopausal Women Aged 50 Years and Older: A Nationwide Cross-Sectional Study. [PDF]

Healthcare (Basel)
Kim S.
europepmc   +1 more source

Fracture risk and initiation of bone‐specific drug therapy following radical cystectomy with urinary diversion

BJU International, EarlyView.
Objectives To assess the risk of fractures among patients with bladder cancer who underwent radical cystectomy (RC) with urinary diversion (UD), compared with matched referents from the general population. Patients/Subjects and Methods We identified 2908 patients who underwent RC between 2011 and 2019, and 13 669 matched referents in a nationwide ...
Mieke Van Hemelrijck, Lars Holmberg, Hans Garmo, Truls Gårdmark, Henrik Kjölhede, Tomas Jerlström, Karin Söderkvist, Anders Ullén, Fredrik Liedberg, Karl Michaëlsson, Christel Häggström   +10 more
wiley   +1 more source

Imaging of Sarcopenia in Type 2 Diabetes Mellitus

Dingyue Wang, Gaosen Zhang, Yana Yu, Zhen Zhang Department of Ultrasound, the First Affiliated Hospital China Medical University, Shenyang City, Liaoning Province, 110001, People’s Republic of ChinaCorrespondence: Zhen Zhang, Email zhangzhen@cmu.edu ...
Zhang G, Zhang Z, Wang D, Yu Y
core  

Glucagon‐like peptide‐1 receptor agonists and muscle strength changes in older adults: Risks beyond muscle mass reductions

British Journal of Pharmacology, EarlyView.
Abstract Gastric inhibitory polypeptide (GIP)/Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are increasingly prescribed for the management of obesity and type 2 diabetes, yet research pertinent to their effects on muscle health is limited. Considering the central role of muscle strength as a sarcopenia component, this article summarizes emerging ...
Konstantinos Prokopidis
wiley   +1 more source

A Preliminary Nomogram for Sarcopenia Screening in Cardiology Outpatients Incorporating Cardiac Structure, Function, and Clinical Variables. [PDF]

Int J Gen Med
Hsu LC, Hung SP, Wang CP, Liaw LJ, Tsai KT, Wu WL, Guo LY, Yang CC.   +7 more
europepmc   +1 more source

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer

British Journal of Pharmacology, EarlyView.
Background and Purpose Musclin (osteocrin) is a skeletal muscle‐derived peptide that has been implicated in cardioprotective signalling pathways. Its relevance in cancer patients, who frequently experience muscle wasting and cardiotoxicity, remains unclear. This study aimed to determine whether circulating Musclin levels reflect functional capacity and
Jannek Brauer, Daniel Finke, Sebastian Romann, Norbert Frey, Joerg Heineke, Lorenz H. Lehmann   +5 more
wiley   +1 more source

Sarcopenia prevalence [PDF]

Osteoporosis International, 2012
M U, Pérez-Zepeda, L M, Gutiérrez-Robledo, V E, Arango-Lopera   +2 more
openaire   +2 more sources

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

British Journal of Pharmacology, EarlyView.
Created in BioRender: Scientific Figure and Illustration Software. Background and Purpose In advanced cancer, associations among changes in body composition, cardiac wasting and prior cardiotoxic anticancer therapy have not been investigated. Experimental Approach Using bioelectrical impedance analysis (BIA), body composition was measured in 206 ...
Sara Hadzibegovic, Jonathan L. Hella, Jan Porthun, Alessia Lena, Danara Krug, Iulia Baluta, Ursula Wilkenshoff, Amir A. Mahabadi, Matthias Totzeck, Tienush Rassaf, Stefan D. Anker, Wolfram Doehner, Ulrich Keller, Lars Bullinger, Dominik P. Modest, Barry J. A. Laird, Richard J. E. Skipworth, John G. F. Cleland, Christian Oeing, Stephan von Haehling, Ulf Landmesser, Markus S. Anker   +21 more
wiley   +1 more source

Sarcopenia Is Associated With Severe Treatment Toxicity and Mortality in Older Adults With Advanced Cancer: A Secondary Analysis. [PDF]

J Cachexia Sarcopenia Muscle
Mattick LJ, Mohammed M, Li CS, Tylock RG, Loh KP, Flannery MA, Peppone LJ, Lin PJ, Goncalves MD, Caan BJ, Cespedes Feliciano EM, Popuri K, Beg MF, Bearden JD, Berenberg J, Katato K, Mustian KM, Mohile SG, Dunne RF.   +18 more
europepmc   +1 more source

Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights

British Journal of Pharmacology, EarlyView.
Cardiac metabolic remodelling in anthracycline‐induced cardiomyopathy and metabolically oriented cardioprotective strategies. Schematic representation of substrate utilization, mitochondrial bioenergetic function and metabolic flexibility in the healthy heart, in anthracycline‐induced cardiomyopathy and under potential cardioprotective interventions ...
Giulia Guerra, Francesco Niro, Marco Mergiotti, Giovanni Gavatorta, Emilio Hirsch, Alessandra Ghigo   +5 more
wiley   +1 more source